首页 > 市场调查报告书 > 医疗设备

静脉曲张治疗市场规模、份额和成长分析（按类型、产品、应用和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898305

静脉曲张治疗市场规模、份额和成长分析（按类型、产品、应用和地区划分）—产业预测（2026-2033 年）

Varicose Veins Treatment Market Size, Share, and Growth Analysis, By Type (Endovenous Ablation, Injection Sclerotherapy), By Products (Ablation Devices, Radiofrequency Ablation Devices), By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球静脉曲张治疗市场预计到 2024 年将达到 13.9 亿美元，到 2025 年将达到 14.8 亿美元，到 2033 年将达到 24.9 亿美元，预测期（2026-2033 年）的复合年增长率为 6.7%。

全球静脉曲张治疗市场正经历强劲成长，这主要受人口老化和久坐生活方式等因素导致疾病盛行率不断上升的推动。人们对有效治疗方法的需求日益增长，尤其是微创手术，例如雷射消熔、硬化疗法和射频消融，这些疗法与传统手术相比具有疼痛更轻、恢復更快、疤痕更少等优势。超音波泡沫硬化疗法和非热消融等技术进步提高了治疗效果，改善了患者的治疗结果和满意度。然而，保险覆盖范围、高成本以及某些地区认知度不足等挑战可能会阻碍市场准入。现有企业和新参与企业之间的激烈竞争需要持续的研发投入，而监管障碍可能会延迟新产品的上市，并影响市场趋势。

全球静脉曲张治疗市场成长要素

全球静脉曲张治疗市场的成长归功于人们对静脉曲张及其各种治疗方案的认识和了解不断提高。公共教育活动、病患教育宣传活动以及跨平台的资讯共用，都促使静脉曲张患者寻求合适的治疗方案。这种认知的提升不仅增强了个人自主管理健康的主导，也提高了他们寻求医疗介入的意愿，从而推动了市场需求。预计更广泛的认知将进一步促进该行业的扩张。

阻碍因素

全球静脉曲张治疗市场面临许多挑战，主要源自于法规要求和产品核可流程的复杂性。製造商在获得必要的核准过程中往往耗时且耗力，这阻碍了新治疗方法和创新技术的及时上市。此外，应对多个国家不同的监管规定也带来了更多挑战，这些障碍不仅影响市场成长，也限制了患者获得先进治疗方案的机会。因此，这些监管障碍可能会减缓有效静脉曲张治疗方法的整体研发和市场推广。

全球静脉曲张治疗市场趋势

全球静脉曲张治疗市场正呈现显着的多模式治疗趋势，协同结合多种治疗治疗方法，以提升患者疗效。整合诸如腔内消融术和硬化疗法等技术，使医疗服务提供者能够有效应对静脉疾病的多个方面，从而提高整体治疗效果并提升患者满意度。这种对综合办法日益增长的偏好，不仅最大限度地提高了治疗效果，也满足了人们对微创高效解决方案日益增长的需求，从而塑造了全球静脉曲张治疗的未来格局。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2023 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2023）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Medtronic plc（Ireland）
AngioDynamics, Inc.（USA）
Teleflex Incorporated（USA）
Boston Scientific Corporation（USA）
Lumenis Ltd.（Israel）
Quanta System SpA（Italy）
Biolitec AG（Austria）
Dornier MedTech GmbH（Germany）
Sciton, Inc.（USA）
Fotona doo（Slovenia）
Viatris Inc.（USA）
Merz Aesthetics（USA）
SIGVARIS Group（Switzerland）
Essity Aktiebolag（publ）（Sweden）
F Care Systems NV（Belgium）
VVT Medical（Israel）
Alma Lasers（Israel）
Energist Group（UK）.
Eufoton srl（Italy）
WONTECH Co., Ltd.（South Korea）

结论与建议

简介目录

Product Code: SQMIG35E2025

Global Varicose Veins Treatment Market size was valued at USD 1.39 Billion in 2024 and is poised to grow from USD 1.48 Billion in 2025 to USD 2.49 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global varicose veins treatment market is witnessing robust growth, driven by the increasing prevalence of this condition due to factors like aging populations and sedentary lifestyles. The demand for effective treatments is on the rise, particularly for minimally invasive procedures such as laser ablation, sclerotherapy, and radiofrequency ablation, which offer advantages like lower pain, quicker recovery, and less scarring compared to traditional surgeries. Technological advancements, including ultrasound-guided foam sclerotherapy and non-thermal ablation, have enhanced treatment efficacy, improving patient outcomes and satisfaction. However, challenges such as reimbursement issues, high costs, and limited awareness in some regions can hinder market accessibility. Intense competition among existing and new players necessitates ongoing research and development, while regulatory hurdles may delay new product launches, impacting market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Varicose Veins Treatment Market Segments Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Varicose Veins Treatment Market

The growth of the Global Varicose Veins Treatment market can be attributed to heightened awareness and education about varicose veins and the various treatment alternatives available. Initiatives aimed at increasing public knowledge, alongside patient education campaigns and information sharing across multiple platforms, have motivated those suffering from varicose veins to pursue suitable treatment options. This surge in understanding has not only empowered individuals to take charge of their health but has also enhanced their willingness to seek medical intervention, thereby driving demand within the market. As awareness continues to spread, it is expected to further support the industry's expansion.

Restraints in the Global Varicose Veins Treatment Market

The global varicose veins treatment market faces significant challenges due to regulatory requirements and the complexities of product approval processes. Manufacturers often encounter prolonged and costly procedures when seeking necessary approvals, which can hinder the timely introduction of novel treatments and innovations. Compliance with diverse regulations across multiple countries adds another layer of difficulty, creating obstacles that can impact market growth and limit the availability of advanced therapeutic options for patients. Consequently, these regulatory hurdles can slow down the overall development and expansion of effective varicose veins treatments in the marketplace.

Market Trends of the Global Varicose Veins Treatment Market

The Global Varicose Veins Treatment market is witnessing a significant trend towards combination therapies, where various treatment modalities are used synergistically to enhance patient outcomes. By integrating techniques like endovenous ablation and sclerotherapy, healthcare providers can effectively address multiple facets of venous disease, improving the overall efficacy of treatments while simultaneously boosting patient satisfaction. This growing preference for comprehensive approaches not only maximizes therapeutic results but also caters to the increasing demand for minimally invasive and efficient solutions, thereby shaping the future landscape of varicose vein management globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2025-2031)

Market Overview
Endovenous Ablation
- Endovenous Laser Therapy
- Radiofrequency Ablation
Injection Sclerotherapy
Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2025-2031)

Market Overview
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2025-2031)

Market Overview
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2025-2031)

North America (Type, Products, End Use)
- US
- Canada
Europe (Type, Products, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Products, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Products, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Products, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumenis Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quanta System S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biolitec AG (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dornier MedTech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciton, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fotona d.o.o. (Slovenia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Aesthetics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SIGVARIS Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essity Aktiebolag (publ) (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F Care Systems NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VVT Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alma Lasers (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Energist Group (UK).
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eufoton s.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WONTECH Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments